Forty Seven Inc (FTSV US)

Forty Seven, Inc. operates as a clinical-stage immuno-oncology company. The Company develops novel checkpoint therapies to activate macrophages targeting cancer immune evasion pathways. Forty Seven serves customers in the State of California.